5 Best Biotech Stocks Under $6 in 2021

4. Dyadic International, Inc. (NASDAQ: DYAI)

Number of Hedge Fund Holders: 5
Price as of April 19, 2021: $4.85 per share

Dyadic International, Inc. (NASDAQ: DYAI) is a Florida-based global biotechnology company. Dyadic concentrates on the improvement and application of a proprietary C1 expression system to help developers and manufacturers bring drugs to the market. It also works on making vaccines and drugs related to antigens, monoclonal antibodies, and fab antibody fragments. Dyadic has a drug in a clinical trial that is slated to help in the development of a new generation of COVID-19 vaccines. The firm is fourth on our list of 10 best biotech stocks under $6 in 2021

Dyadic has signed research and development deals with several companies around the world, including the VTT Technical Research Centre of Finland, the Biotechnology Developments for Industry in Pharmaceuticals, Jiangsu Hengrui Medicine, and Serum Institute of India. The company was founded in 1979. At the end of the fourth quarter of 2020, 5 hedge funds in the database of Insider Monkey held stakes worth $0.9 million in the firm, up from 4 in the preceding quarter.